IVD Excellence: Reliable Tumor Antibodies for Accurate Results

Experience the reliability of our tumor markers. You can read more details about each marker to understand the whole portfolio we are offering. Discover how our high-quality tumor antibodies can help you develop more accurate and reliable diagnostic tests.

Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The use of tumor biomarkers plays a crucial role in screening, diagnosis, and management of cancers, significantly contributing to the reduction in cancer mortality and improving life expectancy.

Alpha-fetoprotein (AFP) (Cat. #4F16): routinely used for screening and diagnosis of Hepatocellular Carcinoma (HCC).

Prostate-specific antigen (PSA) (Cat. # 4P33): assists in screening for prostate cancer and monitoring treatment.

Carcinoembryonic antigen (CEA) (Cat. # 4CA30/4CA30cc): indicates certain types of cancers and monitors treatment.

CA-125 (Cat. # 4C29): routinely used in screening for ovarian cancer (and other related cancers)

CA72-4 (Cat. #4CA72): assists in the diagnosis of gastrointestinal and ovarian cancers and therapeutic monitoring.

CYFRA21-1 (Cat.# 4CY1): assists in differential diagnosis, monitoring, and prognosis of lung cancer.

Human papilloma virus (HPV), type 16, oncoprotein E7 ( Cat. # 3HP16): monitors HPV infections related to cancer.

Human papilloma virus (HPV), type 18, oncoprotein E7 (Cat. # 3HP18): monitors HPV infections related to cancer.


Other tumor biomarkers

Human chorionic gonadotropin (HCG) (Cat. # 2H8): used to diagnose, monitor treatment, and detect recurrence of testicular cancer.

Thyroglobulin (Cat. # 2TG12cc): monitors the treatment of patients with differentiated thyroid cancer (DTC).

Lambda (free) light chains (Cat. # 1L7cc) and Kappa light chains (Cat. # 1K5cc): biomarkers for indicating the multiple myeloma and amyloidosis.

S100 proteins, human (Cat. # 4S37): helps characterize malignant melanoma and some other tumors and provides prognostic values.